Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gestational Diabetes Treatment: Should We Continue Metformin When Starting Insulin? a Randomized Control Trial

NCT06781775 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT06781775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06781775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gestational Diabetes Treatment: Should We Continue Metformin When Starting Insulin? a Randomized Control Trial
Lead sponsor
University of Virginia
Phase
Phase 4
Overall status
Recruiting
Start date
December 12, 2024
Completion date
May 1, 2027
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes